|
Market Closed -
Nasdaq
00:00:00 19/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 68.30 USD | +0.16% |
|
+1.62% | -1.67% |
| 07-31 | UBS Adjusts Exponent Price Target to $72 From $75, Maintains Neutral Rating | MT |
| 07-31 | Exponent, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 84 | +23.19% | 3 | ||||||
| 216.31 | +9.27% | 16 | ||||||
| 162.53 | +12.75% | 15 | ||||||
| 32.44 | +17.57% | 17 | ||||||
| 58.97 | +0.98% | 12 | ||||||
| 24.28 | +15.31% | 12 | ||||||
| 327.83 | +10.83% | 12 | ||||||
| 42.18 | +20.69% | 11 | ||||||
| 44.62 | +25.78% | 8 | ||||||
| 73.5 | +11.87% | 8 | ||||||
| - | 273.33 | +4.62% | 3 | |||||
| 75.14 | +7.38% | 14 | ||||||
| 150.5 | +41.24% | 2 | ||||||
| 1,374 | +8.15% | 5 | ||||||
| 2.091 | -0.73% | 8 | ||||||
| 3.138 | +20.3% | 12 | ||||||
| - | 50.2 | +9.73% | 2 | |||||
| - | 92.5 | +62.82% | 2 | |||||
| 55.93 | +13.45% | 7 | ||||||
| Average | 165.45 | +16.59% | 9 | ||||||
| Weighted average by Cap. | 173.58 | +12.56% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
